SOW
ESPR icon

State of Wyoming’s Esperion Therapeutics ESPR Stock Holding History

State of Wyoming’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$288K Buy
105,182
+41,830
+66% +$132K 0.03% 692
2025
Q4 		$234K Buy
+63,352
New +$205K 0.03% 851
2025
Q3 		– Sell
-122,532
Closed -$121K – 1898
2025
Q2 		$121K Buy
122,532
+32,596
+36% +$32.6K 0.01% 1209
2025
Q1 		$130K Buy
89,936
+43,526
+94% +$80.2K 0.02% 1035
2024
Q4 		$102K Sell
46,410
-31,390
-40% -$73.2K 0.01% 1176
2024
Q3 		$128K Buy
77,800
+12,084
+18% +$24.4K 0.02% 978
2024
Q2 		$146K Buy
+65,716
New +$155K 0.02% 802
2022
Q2 		– Sell
-10,894
Closed -$51K – 1946
2022
Q1 		$51K Buy
+10,894
New +$46.7K 0.03% 1044

Other funds holding ESPR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return